NEW YORK ( TheStreet) -- WuXi PharmaTech (Cayman (NYSE: WX) hit a new 52-week high Monday as it is currently trading at $18.82, above its previous 52-week high of $18.80 with 147,783 shares traded as of 10:52 a.m. ET. Average volume has been 454,500 shares over the past 30 days.

WuXi PharmaTech (Cayman has a market cap of $1.3 billion and is part of the health care sector and drugs industry. Shares are up 14.9% year to date as of the close of trading on Friday.

Wuxi PharmaTech (Cayman) Inc., through its subsidiaries, primarily engages in providing laboratory and manufacturing services to support research and development for pharmaceutical, biotechnology, and medical device companies. The company has a P/E ratio of 15, below the average drugs industry P/E ratio of 15.5 and below the S&P 500 P/E ratio of 17.7.
  • Practice your WX trading strategies and win cash in our stock game.

TheStreet Ratings rates WuXi PharmaTech (Cayman as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, reasonable valuation levels and compelling growth in net income. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. You can view the full WuXi PharmaTech (Cayman Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

Don't Miss Today's Strong And Under The Radar Stock: WuXi PharmaTech (WX)

WuXi PharmaTech (WX) Showing Signs Of Being Strong And Under The Radar

Don't Miss Today's Strong And Under The Radar Stock: WuXi PharmaTech (WX)

Strong And Under The Radar Today: WuXi PharmaTech (WX)

Don't Miss Today's Strong And Under The Radar Stock: WuXi PharmaTech (WX)